Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +6.1% | +20.2% | 2 / 3 | -28.0% | +1.07 pp | +0.94 pp | +6.7% | 1.39 | 6.65 | 3.066 | −28,0% | 92,1 | +5,0% | 6.65 | 5.24 | +26,9% |
| Pts | 0 | 0 | 8 | 0 | 8 | 8 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 11.900 (close price on 2026-10-19)EPS (TTM): 1.789
Financial charts
1.Revenue & growth
VND bn3.066Q2/26
1.Revenue & growth
VND bn3.066Q2/26
2.Profit & growth
VND bn92,5Q2/26
3.Profit mix (Penman)
VND bn350Q2/26
4.Margins & cost structure
%5.9%Q2/26
5.Returns & cash cycle
% · days4.5%Q2/26
6.Earnings quality & cash
VND bn342Q2/26
7.Asset structure
VND bn11.950Q2/26
8.Funding & debt health
VND bn · times11.950Q2/26
9.Revenue backlog
VND bn109Q2/26
10.Valuation
times · %6,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %621Q2/26
Adjusted EPS growth, latest quarter
5.5%
Average adjusted EPS growth, 3 quarters
20.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26